Profile
Arlette H.
Uihlein currently works at Helomics Corp., as Medical Director, American Society of Clinical Oncology, Inc., as Member, and Predictive Oncology, Inc., as SVP-Translational Medicine & Drug Discovery.
Dr. Uihlein received her undergraduate degree from Baldwin-Wallace College and doctorate degree from the University of Toledo Medical Center.
Arlette Uihlein active positions
| Companies | Position | Start |
|---|---|---|
| PRECISION THERAPEUTICS INC | Corporate Officer/Principal | - |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Provides cancer care development and treatment consulting services | Chief Tech/Sci/R&D Officer | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Training of Arlette Uihlein
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Baldwin-Wallace College
Baldwin-Wallace College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toledo Medical Center
University of Toledo Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Provides cancer care development and treatment consulting services | Health Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
Predictive Oncology, Inc.
Predictive Oncology, Inc. Medical SpecialtiesHealth Technology Operates as a development stage company manufacturing an environmentally conscientious system for the collection and disposal of infectious fluids | Health Technology |
- Stock Market
- Insiders
- Arlette Uihlein
















